SCHEMBL9942579

SCHEMBL9942579

Bc1cnc(C)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82304 0.80 — —
SCHEMBL9020435 0.80 — —
Ammonia Solution, Strong SCHEMBL27508580 0.77 — —
SCHEMBL31520440 0.77 UHRF1 (0.41) —
SCHEMBL10021907 0.69 CCR1 (0.41) —
SCHEMBL5666185 0.67 UHRF1 (0.35) —
SCHEMBL426574 0.65 — —
SCHEMBL755027 0.65 — —
SCHEMBL6090433 0.65 — —
SCHEMBL7921671 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-B9 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-11-07 — — EP disclosed
EP-1363705-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-06-13 — — EP disclosed
Send feedback